Charles Schwab Investment Management Inc Biogen Inc. Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,075,757 shares of BIIB stock, worth $157 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,075,757
Previous 1,019,219 5.55%
Holding current value
$157 Million
Previous $139 Million 3.13%
% of portfolio
0.02%
Previous 0.03%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$113.38 - $135.49 $6.41 Million - $7.66 Million
56,538 Added 5.55%
1,075,757 $135 Million
Q1 2025

Sep 15, 2025
SELL
$133.43 - $153.27 $7.54 Million - $8.67 Million
-56,538 Reduced 5.26%
1,019,219 $139 Million
Q1 2025

May 09, 2025
BUY
$133.43 - $153.27 $6.4 Million - $7.35 Million
47,956 Added 4.94%
1,019,219 $139 Million
Q4 2024

Feb 06, 2025
BUY
$146.47 - $191.55 $8.53 Million - $11.2 Million
58,234 Added 6.38%
971,263 $149 Million
Q3 2024

Nov 12, 2024
BUY
$189.07 - $236.8 $2.33 Million - $2.92 Million
12,319 Added 1.37%
913,029 $177 Million
Q2 2024

Aug 12, 2024
BUY
$190.52 - $236.72 $7.98 Million - $9.92 Million
41,905 Added 4.88%
900,710 $209 Million
Q1 2024

May 08, 2024
BUY
$212.02 - $267.71 $2.08 Million - $2.62 Million
9,805 Added 1.15%
858,805 $185 Million
Q4 2023

Feb 06, 2024
BUY
$222.59 - $267.94 $69,002 - $83,061
310 Added 0.04%
849,000 $220 Million
Q3 2023

Nov 08, 2023
SELL
$253.3 - $285.89 $382,736 - $431,979
-1,511 Reduced 0.18%
848,690 $218 Million
Q2 2023

Aug 09, 2023
BUY
$275.25 - $318.06 $1.6 Million - $1.85 Million
5,819 Added 0.69%
850,201 $242 Million
Q1 2023

May 11, 2023
BUY
$256.56 - $292.34 $2.08 Million - $2.36 Million
8,088 Added 0.97%
844,382 $235 Million
Q4 2022

Feb 13, 2023
BUY
$252.44 - $306.72 $3.97 Million - $4.82 Million
15,726 Added 1.92%
836,294 $232 Million
Q3 2022

Nov 14, 2022
BUY
$194.69 - $268.46 $5.97 Million - $8.24 Million
30,684 Added 3.88%
820,568 $219 Million
Q2 2022

Aug 15, 2022
BUY
$187.54 - $223.02 $4.71 Million - $5.6 Million
25,124 Added 3.29%
789,884 $161 Million
Q1 2022

May 13, 2022
BUY
$193.77 - $244.14 $4.46 Million - $5.62 Million
23,023 Added 3.1%
764,760 $161 Million
Q4 2021

Feb 11, 2022
BUY
$223.92 - $287.77 $2.36 Million - $3.03 Million
10,539 Added 1.44%
741,737 $178 Million
Q3 2021

Nov 16, 2021
BUY
$282.99 - $369.05 $2.09 Million - $2.72 Million
7,369 Added 1.02%
731,198 $207 Million
Q2 2021

Aug 16, 2021
BUY
$259.0 - $414.71 $5.07 Million - $8.11 Million
19,565 Added 2.78%
723,829 $251 Million
Q1 2021

May 17, 2021
SELL
$242.95 - $284.63 $1.49 Million - $1.75 Million
-6,138 Reduced 0.86%
704,264 $197 Million
Q4 2020

Feb 16, 2021
SELL
$236.26 - $355.63 $5.83 Million - $8.78 Million
-24,678 Reduced 3.36%
710,402 $174 Million
Q3 2020

Nov 13, 2020
SELL
$264.77 - $305.71 $24 Million - $27.7 Million
-90,630 Reduced 10.98%
735,080 $209 Million
Q2 2020

Aug 14, 2020
SELL
$258.66 - $342.55 $29 Million - $38.4 Million
-112,088 Reduced 11.95%
825,710 $221 Million
Q1 2020

May 15, 2020
BUY
$268.85 - $341.04 $932,102 - $1.18 Million
3,467 Added 0.37%
937,798 $297 Million
Q4 2019

Feb 07, 2020
SELL
$220.06 - $304.07 $7.38 Million - $10.2 Million
-33,539 Reduced 3.47%
934,331 $277 Million
Q3 2019

Nov 08, 2019
BUY
$217.44 - $243.88 $7.97 Million - $8.93 Million
36,633 Added 3.93%
967,870 $225 Million
Q2 2019

Aug 09, 2019
BUY
$219.29 - $241.72 $3.27 Million - $3.61 Million
14,919 Added 1.63%
931,237 $218 Million
Q1 2019

May 14, 2019
BUY
$216.71 - $338.96 $1.5 Million - $2.35 Million
6,944 Added 0.76%
916,318 $217 Million
Q4 2018

Feb 14, 2019
BUY
$278.5 - $352.75 $5.94 Million - $7.52 Million
21,321 Added 2.4%
909,374 $274 Million
Q3 2018

Nov 13, 2018
SELL
$293.51 - $383.83 $9.55 Million - $12.5 Million
-32,534 Reduced 3.53%
888,053 $314 Million
Q2 2018

Aug 08, 2018
BUY
$257.52 - $306.91 $7.32 Million - $8.73 Million
28,440 Added 3.19%
920,587 $267 Million
Q1 2018

May 07, 2018
BUY
$260.13 - $367.91 $15.5 Million - $21.9 Million
59,509 Added 7.15%
892,147 $244 Million
Q4 2017

Jan 17, 2018
BUY
$307.64 - $344.58 $17.3 Million - $19.4 Million
56,333 Added 7.26%
832,638 $265 Million
Q3 2017

Nov 13, 2017
BUY
$281.15 - $329.69 $218 Million - $256 Million
776,305
776,305 $243 Million

Others Institutions Holding BIIB

# of Institutions
1,030
Shares Held
131M
Call Options Held
2.84M
Put Options Held
2.54M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email